| Simple encrypted transmission system suitable for intermittent signals -> Monitor Keywords |
|
Simple encrypted transmission system suitable for intermittent signalsUSPTO Application #: 20070140492Title: Simple encrypted transmission system suitable for intermittent signals Abstract: A signal transmitted from a first device to a second device is encrypted using an encryption key generated from a preceding part of the signal itself. The signal is decrypted in the second device using a decryption key generated from a preceding part of the received and decrypted signal. This encryption method provides effective privacy protection, because the encryption and decryption keys are constantly changing. Since the transmitted signal provides its own encryption and decryption keys, the method is inexpensive to implement, and can be used in systems such as packet transmission systems that transmit signals intermittently. (end of abstract) USPTO Applicaton #: 20070140492 - Class: 380268000 (USPTO) Related Patent Categories: Cryptography, Communication System Using Cryptography, Pseudo-random Sequence Scrambling
Click on the above for other options relating to this Simple encrypted transmission system suitable for intermittent signals patent application. ### 1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored. 3. Each week you receive an email with patent applications related to your keywords. Start now! - Receive info on patent apps like Simple encrypted transmission system suitable for intermittent signals or other areas of interest. ### Previous Patent Application: Method for setting up radio bearer in mobile communication system Next Patent Application: Method for securing data traffic between mobile radio network and ims network Industry Class: Cryptography ### FreshPatents.com Support Thank you for viewing the Simple encrypted transmission system suitable for intermittent signals patent info. IP-related news and info Results in 3.73255 seconds Other interesting Feshpatents.com categories: Accenture , Agouron Pharmaceuticals , Amgen , AT&T , Bausch & Lomb , Callaway Golf |
|||